Managing Toxicity and the Importance of Multidisciplinary Care

In this final segment, the discussion turns to practical challenges patients face during first-line treatment with carboplatin, paclitaxel, and retifanlimab, along with key considerations for optimizing outcomes. Although the addition of immunotherapy has improved disease control and survival, treatment-related toxicity remains an important issue. Patients are exposed to both chemotherapy-related adverse effects such as fatigue, alopecia, myelosuppression, and cumulative peripheral neuropathy and immune-related toxicities associated with PD-1 inhibition, including dermatologic, gastrointestinal, endocrine, and hepatic events. Proactive monitoring and early management are essential, and dose interruptions or discontinuation may be required in some cases.

The treatment schedule itself can also create logistical burdens. Weekly administration of carboplatin and paclitaxel may be challenging for patients who live far from treatment centers, highlighting the need to consider access and feasibility in real-world care. Fortunately, chemotherapy is typically limited to approximately 6 months, after which patients may continue on immunotherapy alone, which is generally better tolerated and associated with relatively low rates of severe toxicity.

Another key theme is symptom management and the role of multidisciplinary care. Patients with advanced disease may have significant tumor-related symptoms, and palliative or consolidative radiation can be an important adjunct, even in the metastatic setting. Importantly, SCAC is a treatment-sensitive disease, and a subset of patients may achieve complete or near-complete responses. In selected cases, integration of systemic therapy followed by consolidative chemoradiation may lead to durable remissions and potential long-term disease control.

The discussion concludes by emphasizing the shift away from chemotherapy alone toward chemo-immunotherapy, the importance of careful patient selection and toxicity monitoring, and the need for coordinated, multidisciplinary management to maximize both survival and quality of life.